Report cover image

Global Peanut Allergy Therapeutics Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 201 Pages
SKU # APRC20359542

Description

Summary

According to APO Research, the global Peanut Allergy Therapeutics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Peanut Allergy Therapeutics market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Peanut Allergy Therapeutics market include Aimmune Therapeutics, ALK Abello, Allergy Therapeutics, Amneal Pharma, ASIT Biotech, DBV Technologies, HAL Allergy, Intrommune Therapeutics and Kaleo, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Peanut Allergy Therapeutics, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Peanut Allergy Therapeutics, also provides the value of main regions and countries. Of the upcoming market potential for Peanut Allergy Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Peanut Allergy Therapeutics revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Peanut Allergy Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Peanut Allergy Therapeutics company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Peanut Allergy Therapeutics Segment by Company

Aimmune Therapeutics
ALK Abello
Allergy Therapeutics
Amneal Pharma
ASIT Biotech
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Kaleo
Perrigo
UCB Pharma
Bayer
GSK
Mylan
J & J
Sanofi
HUAPONT Pharm
Peanut Allergy Therapeutics Segment by Type

Epinephrine Injection
Oral Immunotherapy
Antihistamines
Other
Peanut Allergy Therapeutics Segment by Application

Hospital Pharmacy
Retail Pharmacy
Other
Peanut Allergy Therapeutics Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Peanut Allergy Therapeutics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Peanut Allergy Therapeutics key companies, revenue, market share, and recent developments.
3. To split the Peanut Allergy Therapeutics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Peanut Allergy Therapeutics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Peanut Allergy Therapeutics significant trends, drivers, influence factors in global and regions.
6. To analyze Peanut Allergy Therapeutics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peanut Allergy Therapeutics industry.
Chapter 3: Detailed analysis of Peanut Allergy Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Peanut Allergy Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Peanut Allergy Therapeutics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Table of Contents

201 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Peanut Allergy Therapeutics Market Size, 2020 VS 2024 VS 2031
1.3 Global Peanut Allergy Therapeutics Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Peanut Allergy Therapeutics Market Dynamics
2.1 Peanut Allergy Therapeutics Industry Trends
2.2 Peanut Allergy Therapeutics Industry Drivers
2.3 Peanut Allergy Therapeutics Industry Opportunities and Challenges
2.4 Peanut Allergy Therapeutics Industry Restraints
3 Peanut Allergy Therapeutics Market by Company
3.1 Global Peanut Allergy Therapeutics Company Revenue Ranking in 2024
3.2 Global Peanut Allergy Therapeutics Revenue by Company (2020-2025)
3.3 Global Peanut Allergy Therapeutics Company Ranking (2023-2025)
3.4 Global Peanut Allergy Therapeutics Company Manufacturing Base and Headquarters
3.5 Global Peanut Allergy Therapeutics Company Product Type and Application
3.6 Global Peanut Allergy Therapeutics Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Peanut Allergy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Peanut Allergy Therapeutics Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Peanut Allergy Therapeutics Market by Type
4.1 Peanut Allergy Therapeutics Type Introduction
4.1.1 Epinephrine Injection
4.1.2 Oral Immunotherapy
4.1.3 Antihistamines
4.1.4 Other
4.2 Global Peanut Allergy Therapeutics Sales Value by Type
4.2.1 Global Peanut Allergy Therapeutics Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Peanut Allergy Therapeutics Sales Value by Type (2020-2031)
4.2.3 Global Peanut Allergy Therapeutics Sales Value Share by Type (2020-2031)
5 Peanut Allergy Therapeutics Market by Application
5.1 Peanut Allergy Therapeutics Application Introduction
5.1.1 Hospital Pharmacy
5.1.2 Retail Pharmacy
5.1.3 Other
5.2 Global Peanut Allergy Therapeutics Sales Value by Application
5.2.1 Global Peanut Allergy Therapeutics Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Peanut Allergy Therapeutics Sales Value by Application (2020-2031)
5.2.3 Global Peanut Allergy Therapeutics Sales Value Share by Application (2020-2031)
6 Peanut Allergy Therapeutics Regional Value Analysis
6.1 Global Peanut Allergy Therapeutics Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Peanut Allergy Therapeutics Sales Value by Region (2020-2031)
6.2.1 Global Peanut Allergy Therapeutics Sales Value by Region: 2020-2025
6.2.2 Global Peanut Allergy Therapeutics Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Peanut Allergy Therapeutics Sales Value (2020-2031)
6.3.2 North America Peanut Allergy Therapeutics Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Peanut Allergy Therapeutics Sales Value (2020-2031)
6.4.2 Europe Peanut Allergy Therapeutics Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Peanut Allergy Therapeutics Sales Value (2020-2031)
6.5.2 Asia-Pacific Peanut Allergy Therapeutics Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Peanut Allergy Therapeutics Sales Value (2020-2031)
6.6.2 South America Peanut Allergy Therapeutics Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Peanut Allergy Therapeutics Sales Value (2020-2031)
6.7.2 Middle East & Africa Peanut Allergy Therapeutics Sales Value Share by Country, 2024 VS 2031
7 Peanut Allergy Therapeutics Country-level Value Analysis
7.1 Global Peanut Allergy Therapeutics Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Peanut Allergy Therapeutics Sales Value by Country (2020-2031)
7.2.1 Global Peanut Allergy Therapeutics Sales Value by Country (2020-2025)
7.2.2 Global Peanut Allergy Therapeutics Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.3.2 USA Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.4.2 Canada Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.6.2 Germany Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.7.2 France Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.7.3 France Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.9.2 Italy Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.10.2 Spain Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.11.2 Russia Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.14.2 China Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.14.3 China Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.15.2 Japan Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.17.2 India Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.17.3 India Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.18.2 Australia Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.22.2 Chile Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.24.2 Peru Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.26.2 Israel Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.27.2 UAE Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.29.2 Iran Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Peanut Allergy Therapeutics Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Peanut Allergy Therapeutics Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Peanut Allergy Therapeutics Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Aimmune Therapeutics
8.1.1 Aimmune Therapeutics Comapny Information
8.1.2 Aimmune Therapeutics Business Overview
8.1.3 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.1.4 Aimmune Therapeutics Peanut Allergy Therapeutics Product Portfolio
8.1.5 Aimmune Therapeutics Recent Developments
8.2 ALK Abello
8.2.1 ALK Abello Comapny Information
8.2.2 ALK Abello Business Overview
8.2.3 ALK Abello Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.2.4 ALK Abello Peanut Allergy Therapeutics Product Portfolio
8.2.5 ALK Abello Recent Developments
8.3 Allergy Therapeutics
8.3.1 Allergy Therapeutics Comapny Information
8.3.2 Allergy Therapeutics Business Overview
8.3.3 Allergy Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.3.4 Allergy Therapeutics Peanut Allergy Therapeutics Product Portfolio
8.3.5 Allergy Therapeutics Recent Developments
8.4 Amneal Pharma
8.4.1 Amneal Pharma Comapny Information
8.4.2 Amneal Pharma Business Overview
8.4.3 Amneal Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.4.4 Amneal Pharma Peanut Allergy Therapeutics Product Portfolio
8.4.5 Amneal Pharma Recent Developments
8.5 ASIT Biotech
8.5.1 ASIT Biotech Comapny Information
8.5.2 ASIT Biotech Business Overview
8.5.3 ASIT Biotech Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.5.4 ASIT Biotech Peanut Allergy Therapeutics Product Portfolio
8.5.5 ASIT Biotech Recent Developments
8.6 DBV Technologies
8.6.1 DBV Technologies Comapny Information
8.6.2 DBV Technologies Business Overview
8.6.3 DBV Technologies Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.6.4 DBV Technologies Peanut Allergy Therapeutics Product Portfolio
8.6.5 DBV Technologies Recent Developments
8.7 HAL Allergy
8.7.1 HAL Allergy Comapny Information
8.7.2 HAL Allergy Business Overview
8.7.3 HAL Allergy Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.7.4 HAL Allergy Peanut Allergy Therapeutics Product Portfolio
8.7.5 HAL Allergy Recent Developments
8.8 Intrommune Therapeutics
8.8.1 Intrommune Therapeutics Comapny Information
8.8.2 Intrommune Therapeutics Business Overview
8.8.3 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.8.4 Intrommune Therapeutics Peanut Allergy Therapeutics Product Portfolio
8.8.5 Intrommune Therapeutics Recent Developments
8.9 Kaleo
8.9.1 Kaleo Comapny Information
8.9.2 Kaleo Business Overview
8.9.3 Kaleo Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.9.4 Kaleo Peanut Allergy Therapeutics Product Portfolio
8.9.5 Kaleo Recent Developments
8.10 Perrigo
8.10.1 Perrigo Comapny Information
8.10.2 Perrigo Business Overview
8.10.3 Perrigo Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.10.4 Perrigo Peanut Allergy Therapeutics Product Portfolio
8.10.5 Perrigo Recent Developments
8.11 UCB Pharma
8.11.1 UCB Pharma Comapny Information
8.11.2 UCB Pharma Business Overview
8.11.3 UCB Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.11.4 UCB Pharma Peanut Allergy Therapeutics Product Portfolio
8.11.5 UCB Pharma Recent Developments
8.12 Bayer
8.12.1 Bayer Comapny Information
8.12.2 Bayer Business Overview
8.12.3 Bayer Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.12.4 Bayer Peanut Allergy Therapeutics Product Portfolio
8.12.5 Bayer Recent Developments
8.13 GSK
8.13.1 GSK Comapny Information
8.13.2 GSK Business Overview
8.13.3 GSK Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.13.4 GSK Peanut Allergy Therapeutics Product Portfolio
8.13.5 GSK Recent Developments
8.14 Mylan
8.14.1 Mylan Comapny Information
8.14.2 Mylan Business Overview
8.14.3 Mylan Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.14.4 Mylan Peanut Allergy Therapeutics Product Portfolio
8.14.5 Mylan Recent Developments
8.15 J & J
8.15.1 J & J Comapny Information
8.15.2 J & J Business Overview
8.15.3 J & J Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.15.4 J & J Peanut Allergy Therapeutics Product Portfolio
8.15.5 J & J Recent Developments
8.16 Sanofi
8.16.1 Sanofi Comapny Information
8.16.2 Sanofi Business Overview
8.16.3 Sanofi Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.16.4 Sanofi Peanut Allergy Therapeutics Product Portfolio
8.16.5 Sanofi Recent Developments
8.17 HUAPONT Pharm
8.17.1 HUAPONT Pharm Comapny Information
8.17.2 HUAPONT Pharm Business Overview
8.17.3 HUAPONT Pharm Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
8.17.4 HUAPONT Pharm Peanut Allergy Therapeutics Product Portfolio
8.17.5 HUAPONT Pharm Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.